chr2-47798724-AC-A

Variant names:

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000179.3(MSH6):c.742delC(p.Arg248GlufsTer31) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R248R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)

Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

MSH6
NM_000179.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 0.846

Publications

3 publications found

Variant links:

Genes affected

MSH6 (HGNC:7329): (mutS homolog 6) This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]

MSH6 links:

FBXO11 (HGNC:13590): (F-box protein 11) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. It can function as an arginine methyltransferase that symmetrically dimethylates arginine residues, and it acts as an adaptor protein to mediate the neddylation of p53, which leads to the suppression of p53 function. This gene is known to be down-regulated in melanocytes from patients with vitiligo, a skin disorder that results in depigmentation. Polymorphisms in this gene are associated with chronic otitis media with effusion and recurrent otitis media (COME/ROM), a hearing loss disorder, and the knockout of the homologous mouse gene results in the deaf mouse mutant Jeff (Jf), a single gene model of otitis media. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]

FBXO11 Gene-Disease associations (from GenCC):

intellectual developmental disorder with dysmorphic facies and behavioral abnormalities
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

FBXO11 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1

Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.

PM2

Very rare variant in population databases, with high coverage;

PP5

Variant 2-47798724-AC-A is Pathogenic according to our data. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47798724-AC-A is described in CliVar as Pathogenic. Clinvar id is 141365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MSH6	NM_000179.3 link	c.742delC	p.Arg248GlufsTer31	frameshift_variant	Exon 4 of 10	ENST00000234420.11	NP_000170.1	P52701-1Q3SWU9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MSH6	ENST00000234420.11 link	c.742delC	p.Arg248GlufsTer31	frameshift_variant	Exon 4 of 10	1	NM_000179.3	ENSP00000234420.5		P52701-1

Frequencies

GnomAD3 genomes

AF:

0.0000131

AC:

AN:

152222

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000241

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.0000655

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.00000398

AC:

AN:

251158

AF XY:

0.00000737

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00000881

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

6.84e-7

AC:

AN:

1461876

Hom.:

Cov.:

AF XY:

0.00

AC XY:

AN XY:

727240

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33480

American (AMR)

AF:

0.00

AC:

AN:

44724

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26136

East Asian (EAS)

AF:

0.00

AC:

AN:

39700

South Asian (SAS)

AF:

0.00

AC:

AN:

86258

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53406

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

8.99e-7

AC:

AN:

1112008

Other (OTH)

AF:

0.00

AC:

AN:

60396

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.425

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000131

AC:

AN:

152222

Hom.:

Cov.:

AF XY:

0.00

AC XY:

AN XY:

74384

show subpopulations

African (AFR)

AF:

0.0000241

AC:

AN:

41456

American (AMR)

AF:

0.0000655

AC:

AN:

15272

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5204

South Asian (SAS)

AF:

0.00

AC:

AN:

4836

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10624

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

68040

Other (OTH)

AF:

0.00

AC:

AN:

2090

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.550

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Alfa

AF:

0.00

Hom.:

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:9

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Pathogenic:2

Mar 17, 2023

GeneDx

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Identified in patients with colorectal or breast cancer (AlDubayan et al., 2018; Huang et al., 2018; Lu et al., 2019); This variant is associated with the following publications: (PMID: 28152038, 30787465, 20301390, 24362816, 18269114, 29703791, 30279230, 29478780, 29625052, 29922827, 35070997, 28514183, 30128536) -

Jan 08, 2020

Quest Diagnostics Nichols Institute San Juan Capistrano

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and not found in general population data. -

Hereditary cancer-predisposing syndrome

Pathogenic:2

Feb 17, 2022

Sema4, Sema4

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:curation

- -

Nov 07, 2024

Ambry Genetics

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The c.742delC pathogenic mutation, located in coding exon 4 of the MSH6 gene, results from a deletion of one nucleotide at nucleotide position 742, causing a translational frameshift with a predicted alternate stop codon (p.R248Efs*31). This alteration was observed in a colorectal cancer cohort (AlDubayan SH et al. Am. J. Hum. Genet. 2018 Mar;102(3):401-414) and in an individual diagnosed with breast cancer (Lu HM et al. JAMA Oncol, 2019 01;5:51-57). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -

Lynch syndrome 5

Pathogenic:1

Aug 10, 2023

Myriad Genetics, Inc.

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -

Hereditary nonpolyposis colon cancer

Pathogenic:1

Jan 29, 2022

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Variant summary: MSH6 c.742delC (p.Arg248GlufsX31) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 251158 control chromosomes. c.742delC has been reported in the literature in individuals affected with Hereditary cancers/colorectal cancers (example, Espenschied_2017, LaDuca_2017, AlDubayan_2018). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Lynch syndrome

Pathogenic:1

Oct 23, 2023

All of Us Research Program, National Institutes of Health

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant deletes 1 nucleotide in exon 4 of the MSH6 gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been observed in individuals affected with breast, colorectal, and unspecified cancers (PMID: 29478780, 29625052, 30128536, 35070997). This variant has been identified in 2/282566 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of MSH6 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -

Hereditary nonpolyposis colorectal neoplasms

Pathogenic:1

Jan 20, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg248Glufs*31) in the MSH6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH6 are known to be pathogenic (PMID: 18269114, 24362816). This variant is present in population databases (rs587781691, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with Lynch syndrome (PMID: 28514183). Invitae Evidence Modeling of clinical and family history, age, sex, and reported ancestry of multiple individuals with this MSH6 variant has been performed. This variant is expected to be pathogenic with a positive predictive value of at least 99%. This is a validated machine learning model that incorporates the clinical features of 1,370,736 individuals referred to our laboratory for MSH6 testing. ClinVar contains an entry for this variant (Variation ID: 141365). For these reasons, this variant has been classified as Pathogenic. -

Endometrial carcinoma

Pathogenic:1

Mar 20, 2023

Baylor Genetics

Significance:Pathogenic

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

PhyloP100

0.85

Mutation Taster

=0/200

disease causing (ClinVar)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over